Live Chat Software
February 26-28, 2018
United States

Main Day 2

9:00 am - 9:45 am Personalized Medicine and its Repercussions on Pharmacovigilance

Lisa Bernaise - Global Head, Device Safety Galderma
img

Lisa Bernaise

Global Head, Device Safety
Galderma

10:00 am - 10:45 am Utilizing a Digital World for Adverse Drug Reactions (ADRs) to Increase your Quality Data Globally

11:15 am - 12:00 pm Strategies for Interpreting Regulations Globally

Francesca Kolitsopoulos - Director, Epidemiology Strategic Implementation Lead Pfizer
img

Francesca Kolitsopoulos

Director, Epidemiology Strategic Implementation Lead
Pfizer

12:00 pm - 12:45 pm Spotlight: Asia as a Key Market for Pharmacovigilance

Rahul Khajuria - Director Global Drug Safety Systems & Analytics United Therapeutics Corporation
img

Rahul Khajuria

Director Global Drug Safety Systems & Analytics
United Therapeutics Corporation

img

Rahul Khajuria

Director Global Drug Safety Systems & Analytics
United Therapeutics Corporation

img

Ale (Maria) Vazquez-Gragg

VP, Global Patient Safety
Intarcia Therapeutics, Inc

Agnieszka Majcher-Dann

Head of Safety Sciences and Policy, Consumer Segment
Johnson and Johnson

2:30 pm - 3:15 pm Mapping out a Risk Management Plan (RMP)

Ale (Maria) Vazquez-Gragg - VP, Global Patient Safety Intarcia Therapeutics, Inc
img

Ale (Maria) Vazquez-Gragg

VP, Global Patient Safety
Intarcia Therapeutics, Inc

3:45 pm - 4:30 pm Monitoring EudraVigilance: Your Role and Responsibilities

Agnieszka Majcher-Dann - Head of Safety Sciences and Policy, Consumer Segment Johnson and Johnson

Agnieszka Majcher-Dann

Head of Safety Sciences and Policy, Consumer Segment
Johnson and Johnson

4:30 pm - 5:15 pm Zeroing in on FAERS: Suggested Fixes to FDA's Adverse Event Database

Susan DiMaggio - Director, Vendor and Alliance Management Alexion Pharmaceuticals, Inc.
img

Susan DiMaggio

Director, Vendor and Alliance Management
Alexion Pharmaceuticals, Inc.